SIFCO Industries, Inc. — Form 10-Q Summary
Reporting period: Fiscal second quarter and six months ended March 31, 2022; comparisons are to the periods ended March 31, 2021. Amounts below are in millions except per-share data.
Business context and results
SIFCO manufactures forged and machined components primarily for aerospace and energy markets and reports one operating segment. Fiscal Q2 results include a $5.1 million gain from forgiveness of the company’s Paycheck Protection Program (PPP) loan.
| Metric | Q2 FY2022 | Q2 FY2021 | Six months FY2022 | Six months FY2021 |
|---|---|---|---|---|
| Net sales | $24.6 | $24.9 | $43.8 | $49.9 |
| Gross profit / margin | $1.5 / 5.9% | $2.7 / 11.0% | $1.5 / 3.3% | $6.7 / 13.3% |
| Operating income (loss) | $(1.3) | $(1.1) | $(4.9) | $1.2 |
| Net income (loss) | $3.6 | $(1.5) | $(0.1) | $1.5 |
| Diluted EPS | $0.61 | $(0.26) | $(0.01) | $0.25 |
| Adjusted EBITDA | $0.7 | $1.2 | $(1.0) | $3.1 |
Six-month operating cash flow was a use of $3.2 million, versus cash provided of $5.8 million a year earlier. Capital expenditures were $1.5 million. Cash was $0.1 million at March 31, 2022, down from $0.3 million at September 30, 2021.
Total debt was $20.4 million, including $12.8 million outstanding on the revolver; current maturities were $17.1 million. Revolving availability was $12.8 million. Current assets were $47.4 million and current liabilities were $33.8 million. The filing states covenant calculations were not required because availability exceeded 10% of the revolving commitment.
Material changes and drivers
- Six-month sales fell $6.1 million year over year. Rotorcraft sales declined $7.7 million and energy power-generation sales fell $3.5 million; commercial products and other revenue rose $5.1 million, primarily from munitions-program order timing and commercial space sales.
- Lower sales volume, idle expense, material and natural-gas costs drove the six-month gross margin decline. In Q2, cost of goods sold rose despite slightly lower sales, with higher material, idle and energy costs cited.
- Q2 net income was driven by the $5.1 million PPP-loan forgiveness gain, not operating profitability: the company recorded a $1.3 million operating loss. Six-month results also compare with prior-year insurance recoveries of $2.5 million and a favorable tax benefit.
- Backlog was $72.0 million at March 31, 2022, down from $82.3 million a year earlier. The filing cautions that orders may be modified or cancelled and backlog may not predict future sales.
Outlook, risks and unusual items
Management expects operating cash flows and available borrowing capacity to meet anticipated cash needs over the next 12 months. Remaining FY2022 capital expenditures were expected to be $2.0–$3.0 million, primarily for production capabilities and cost reductions. The company reported $1.2 million of capital commitments at March 31.
Management cited continuing COVID-19 effects, uncertain commercial aerospace recovery, customer order and supplier-material delays, supply-chain and transportation pressure, geopolitical disruption, and increased material, energy and commodity costs. Other stated risks include demand and military-spending levels, customer concentration, competition, workforce availability, pension funding, and access to financing. Management said disclosure controls were effective as of March 31, 2022, with no material change in internal control over financial reporting.
On March 23, 2022, amendments to the credit and export credit agreements transitioned reference rates from LIBOR to SOFR and changed borrowing-base and covenant terms, including exclusion of the first $1.5 million of unfunded capital expenditures from the fixed-coverage calculation through April 20, 2023. The PPP loan, including accrued interest, was forgiven in January 2022; the $5.1 million gain was recognized when the company was legally released from the obligation.
Investor verification points
- Assess whether the sharp gross-margin decline and operating losses improve as volume, idle capacity, supply constraints and input costs change.
- Separate recurring operating performance from the one-time PPP forgiveness gain and prior-year insurance and tax benefits.
- Monitor cash consumption, working capital—especially the $2.6 million six-month inventory increase—and revolver availability and covenant headroom.
- Check whether backlog converts to revenue on schedule, given its year-over-year decline and customers’ ability to modify or cancel orders.
- Verify the timing and funding of planned capital expenditures and management’s stated liquidity expectations amid continued market uncertainty.